We are honored to congratulate Prof. Tomer Shlomi from our Faculty and The Taub Faculty of Computer Science Technion at the Technion on the significant acquisition of MetaSight Diagnostics by the global diagnostics leader, Guardant Health!
MetaSight, co-founded by Prof. Shlomi in collaboration with aMoon Fund, has developed pioneering liquid biopsy technology for the early detection of cancer. The acquisition, valued at up to $150 million, underscores the profound impact of academic research on the global healthcare industry.
Following this milestone, Guardant Health has announced it will establish its first international R&D center in Israel.
This achievement demonstrates that deep scientific expertise is not only the key to clinical breakthroughs but also the driver behind world-class biotechnology ventures and high-value industrial exits!
We extend our warmest congratulations to Prof. Shlomi and the entire MetaSight team on this extraordinary accomplishment.
